HPR149 Generic Pricing Policy Frees Up $1 Billion: Statin Pricing and Expenditure from 2010-2022 in Australia.

Abstract

Authors

L. Lee H. Kim

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×